Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

STAAR SURGICAL COMPANY

(STAA)
  Report
Delayed Quote. Delayed Nasdaq - 10/26 04:00:00 pm
120.7 USD   -3.15%
10/20STAAR SURGICAL : to Report Third Quarter Results on November 3, 2021
BU
10/06INSIDER SELL : Staar Surgical
MT
10/01Broadwood Capital Engages in Discussions with STAAR Surgical
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

STAAR SURGICAL CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

08/10/2021 | 06:07am EDT

Item 7.01 Regulation FD Disclosure.

Representatives of STAAR Surgical Company will give presentations to investors commencing on August 10, 2021. A copy of the slide presentation they will share is furnished as Exhibit 99.1 to this Report and is incorporated herein by this reference.

This information and the information contained in the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report, and Exhibit 99.1 are not incorporated by reference into any filings of STAAR made under the Securities Act of 1933, as amended, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 9.01 Financial Statements and Exhibits



Exhibit No.   Description
99.1            Slide presentation dated August 2021.

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

© Edgar Online, source Glimpses

All news about STAAR SURGICAL COMPANY
10/20STAAR SURGICAL : to Report Third Quarter Results on November 3, 2021
BU
10/06INSIDER SELL : Staar Surgical
MT
10/01Broadwood Capital Engages in Discussions with STAAR Surgical
CI
09/24STAAR SURGICAL CO : Change in Directors or Principal Officers (form 8-K)
AQ
09/17INSIDER SELL : Staar Surgical
MT
09/09INSIDER SELL : STAAR Surgical
MT
09/03INSIDER SELL : Staar Surgical
MT
08/10STAAR SURGICAL CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/05STAAR SURGICAL CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/05SECTOR UPDATE : Health Care Stocks Trim Losses Late
MT
More news
Analyst Recommendations on STAAR SURGICAL COMPANY
More recommendations
Financials (USD)
Sales 2021 229 M - -
Net income 2021 23,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 256x
Yield 2021 -
Capitalization 5 720 M 5 720 M -
Capi. / Sales 2021 25,0x
Capi. / Sales 2022 19,7x
Nbr of Employees 575
Free-Float 99,5%
Chart STAAR SURGICAL COMPANY
Duration : Period :
STAAR Surgical Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STAAR SURGICAL COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 120,70 $
Average target price 147,00 $
Spread / Average Target 21,8%
EPS Revisions
Managers and Directors
Caren L. Mason President, Chief Executive Officer & Director
Patrick F. Williams Chief Financial Officer & Vice President
Louis E. Silverman Chairman
Keith Holliday Chief Technology Officer
Scott D. Barnes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
STAAR SURGICAL COMPANY54.61%5 906
ABBOTT LABORATORIES15.61%224 403
MEDTRONIC PLC5.48%166 288
BECTON, DICKINSON AND COMPANY-1.52%70 767
HOYA CORPORATION21.09%55 682
DEXCOM, INC.53.72%54 986